Genomic Presents Oncotype Results - Analyst Blog
12/13/2012 11:50:01 AM - Zacks.com
Can Amgen Unlock DeCODE's Value?
12/10/2012 12:44:00 PM - Seeking Alpha
Meridian Bioscience Inc. (VIVO) Ex-Dividend Date Scheduled for December 12, 2012
12/10/2012 10:00:04 AM - NASDAQ.com News
Testing, Testing: Analyst Kevin DeGeeter On 5 Good Bets In Cancer Diagnostics
11/30/2012 9:02:00 AM - Seeking Alpha
Myriad Genetics - Momentum
11/20/2012 1:00:01 AM - Zacks.com
Strong 1Q from Myriad, Guidance Up - Analyst Blog
11/6/2012 9:10:01 AM - Zacks.com
Qiagen: Downside Priced In, CDx And Automation Upside, Undervalued Compared To Peers
9/29/2012 4:09:00 AM - Seeking Alpha
6 Low-Debt Mid Caps With Plenty Of Cash
9/24/2012 5:05:00 PM - Seeking Alpha
Myriad Remains Neutral - Analyst Blog
9/21/2012 3:34:57 PM - Zacks.com
Bearish combination targets Myriad
8/29/2012 12:32:52 PM - optionMONSTER
Cepheid Remains Neutral - Analyst Blog
8/22/2012 2:32:51 PM - Zacks.com
Myriad Wins Patent Ruling Again - Analyst Blog
8/20/2012 7:33:29 PM - Zacks.com
Myriad Meets EPS, Revs Beat - Analyst Blog
8/15/2012 2:02:01 PM - Zacks.com
Genomic Health Targets Middle East - Analyst Blog
8/14/2012 4:15:01 PM - Zacks.com
After-Hours Earnings Report for August 14, 2012 : JKHY, JDSU, PAAS, MYGN, SID, HBM, AGRO, BOBE, PLAB, KONG, SHOR, AOSL
8/14/2012 12:00:00 AM - NASDAQ.com News
Cautious trade before Myriad results
7/31/2012 11:26:48 AM - optionMONSTER
FDA Approves Qiagen's KRAS Test - Analyst Blog
7/9/2012 10:48:00 AM - Zacks.com
Genomic Health to Outperform - Analyst Blog
7/6/2012 3:30:01 PM - Zacks.com
Cepheid Expands European Portfolio - Analyst Blog
5/29/2012 3:30:01 PM - Zacks.com
FDA Nod for Cepheid's Infinity-80 - Analyst Blog
5/25/2012 10:44:31 AM - Zacks.com
Myriad in Research Partnership - Analyst Blog
5/22/2012 3:30:01 PM - Zacks.com
Genomic Health Stays Neutral - Analyst Blog
5/21/2012 3:39:05 PM - Zacks.com
Myriad Reiterated Neutral - Analyst Blog
5/18/2012 2:40:41 PM - Zacks.com
Myriad to Present Cancer Test Study - Analyst Blog
5/17/2012 3:40:39 PM - Zacks.com
Cepheid Back to Neutral - Analyst Blog
5/14/2012 3:06:48 PM - Zacks.com
